Light regulatory touch called appropriate for mobile health apps
In many aspects, witnesses recognized that a light regulatory touch was called for, as the FDA, FTC and Congress itself could not keep pace with the rate of industry innovation.
In many aspects, witnesses recognized that a light regulatory touch was called for, as the FDA, FTC and Congress itself could not keep pace with the rate of industry innovation.
Breaking out of research silos and collaborating more openly will be a big step in driving personalized medicine forward, said Dr. Andrew Futreal, a professor of genomic medicine at MD Anderson. Futreal was one of a dozen personal-medicine experts from the private, public and academic sectors who spoke at a Path2Cures hearing Wednesday in front of the House Energy […]
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.